Abstract
This study describes the incorporation of a coumarin-rich extract from Pterocaulon balansae into nanoemulsions intended for the local treatment of ocular keratitis caused by Acanthamoeba. The n-hexane dewaxed extract of P. balansae was characterized by HPLC/PDA and UPLC/MS. The presence of four major coumarins was detected, where 5-methoxy-6,7-methylenedioxycoumarin was selected as a chemical marker. This extract was then incorporated into nanoemulsions composed of medium chain triglycerides and egg-lecithin, through spontaneous emulsification. Such a procedure yielded the formation of monodisperse nanoemulsions in a sub-300-nm range, regardless of the amount of extract incorporated (1.0–5.0 mg/mL). The amoebicidal activity against Acanthamoeba castellanii was both dose-dependent and incubation time-dependent. A reduction of 95% of trophozoite viability was detected after 24 h of incubation with a nanoemulsion at 1.25 mg/mL of coumarins, being a similar effect detected for chlorhexidine. These results suggest a potential of the formulations developed in this study as a new strategy for the treatment of ocular keratitis caused by Acanthamoeba.
Similar content being viewed by others
References
Illingworth CD, Cook SD. Acanthamoeba keratitis. Surv Ophthalmol. 1998;42:493–508.
Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol. 2007;50:1–26.
Panjwani N. Pathogenesis of Acanthamoeba keratitis. Ocul Surf. 2010;8(2):70–9.
Trabelsi H, Dendana F, Sellami A, Sellami H, Cheikhrouhou F, Neji S, et al. Pathogenic free-living amoebae: epidemiology and clinical review. Pathologie Biologie. 2012;No prelo:7 páginas.
Khan NA. Acanthamoeba: biology and increasing importance in human health. Microbiol Rev. 2006;30:564–95.
Clarke B, Sinha A, Parmar DN, Sykakis E. Advances in the diagnosis and treatment of Acanthamoeba keratitis. J Ophthalmol. 2012;2012:6. doi:10.1155/2012/484892.
Control CoD. http://www.cdc.gov/parasites/acanthamoeba/. 2012. Last access on the 3rd of July 2012.
Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003;16:273–307.
Regner GG, Gianesini J, Von Borowski RG, Silveira F, Semedo JG, Ferraz ABF, et al. Toxicological evaluation of Pterocaulon polystachyum extract: a medicinal plant with antifungal activity. Environ Toxicol Pharmacol. 2011;31(1):242–9. doi:10.1016/j.etap.2010.11.003.
Stopiglia CDO, da Rocha VD, de Carvalho MG, Teixeira H, von Poser GL, Scroferneker ML. Antifungal activity of Pterocaulon species (Asteraceae) against Sporothrix schenckii. J Mycol Med. 2011;21(3):169–72. doi:10.1016/j.mycmed.2011.07.002.
Daboit TC, Stopiglia CDO, Von Poser GL, Scroferneker ML. Antifungal activity of Pterocaulon alopecuroides (Asteraceae) against chromoblastomycosis agents. Mycoses. 2010;53(3):246–50. doi:10.1111/j.1439-0507.2009.01704.x.
Sauter I, dos Santos J, Apel M, Cibulski S, Roehe P, von Poser G, et al. Amoebicidal activity and chemical composition of Pterocaulon polystachyum (Asteraceae) essential oil. Parasitol Res. 2011;109(5):1367–71. doi:10.1007/s00436-011-2383-7.
Alarcón R, Flores RC, Ocampos S, Lucatti A, Galleguillo LF, Tonn C, et al. Flavonoids from Pterocaulon alopecuroides with antibacterial activity. Planta Med. 2008;74(12):1463–7.
Stein AC, Sortino M, Avancini C, Zacchino S, von Poser G. Ethnoveterinary medicine in the search for antimicrobial agents: antifungal activity of some species of Pterocaulon (Asteraceae). J Ethnopharmacol. 2005;99(2):211–4. doi:10.1016/j.jep.2005.02.011.
Stein AC, Álvarez S, Avancini C, Zacchino S, von Poser G. Antifungal activity of some coumarins obtained from species of Pterocaulon (Asteraceae). J Ethnopharmacol. 2006;107(1):95–8. doi:10.1016/j.jep.2006.02.009.
Ródio C, da Rocha VD, Kowalski K, Panatieri L, von Poser G, Rott M. In vitro evaluation of the amebicidal activity of Pterocaulon polystachyum (Asteraceae) against trophozoites of Acanthamoeba castellanii. Parasitol Res. 2008;104(1):191–4. doi:10.1007/s00436-008-1186-y.
Iqbal PF, Bhat AR, Azam A. Antiamoebic coumarins from the root bark of Adina cordifolia and their new thiosemicarbazone derivatives. Eur J Med Chem. 2009;44(5):2252–9. doi:10.1016/j.ejmech.2008.06.003.
Camacho MR, Phillipson JD, Croft SL, Yardley V, Solis PN. In vitro antiprotozoal and cytotoxic activities of some alkaloids, quinones, flavonoids, and coumarins. Planta Med. 2004;70(1):70–2.
Schmidt TJ, Khalid SA, Romanha AJ, Alves TM, Biavatti MW, Brun R, et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases—part II. Curr Med Chem. 2012;19(14):2176–228.
Zorzi GK, Carvalho ELS, von Poser GL, Teixeira H. On the use of nanotechnology-based strategies for association of complex matrices from plant extracts. Braz J Pharmacognosy. 2015;25:426–36.
Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. Nano-emulsions. Curr Opin Colloid Interface Sci. 2005;10(3–4):102–10. doi:10.1016/j.cocis.2005.06.004.
Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interf Sci. 2004;108–109:303–18.
Napolitano HB, Silva M, Ellena J, Rodrigues BDG, Almeida ALC, Vieira PC, et al. Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes. Braz J Med Biol Res. 2004;37:1847–52.
Brenzan M, Nakamura C, Prado Dias Filho B, Ueda-Nakamura T, Young M, Aparício Garcia Cortez D. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis. Parasitol Res. 2007;101(3):715–22. doi:10.1007/s00436-007-0542-7.
Medeiros-Neves B, de Barros FMC, Teixeira HF, von Poser GL. Quantification of coumarins in aqueous extract of Pterocaulon balansae (Asteraceae) and characterization of a new compound. Molecules. 2015;20(10):18083–94.
Murray RDH, Méndez J, Brown SA. The natural coumarins: occurrence, chemistry, and biochemistry. In: Harborne JB, editor. Plant, cell & environment. 21st ed. New York: J. Wiley Sons Ltd; 1982. p. 435–6.
Debenedetti SL, De Kimpe N, Boeykens M, Coussio JD, Kesteleyn B. Structural revision of four coumarins from Pterocaulon species. Phytochemistry. 1997;45(7):1515–7. doi:10.1016/S0031-9422(97)00174-X.
Magalhães AF, Magalhães EG, Leitão Filho HF, Frighetto RTS, Barros SMG. Coumarins from Pterocaulon balansae and P. lanatum. Phytochemistry. 1981;20(6):1369–71. doi:10.1016/0031-9422(81)80042-8.
Bidone J, Zorzi GK, Carvalho ELS, Simões CMO, Koester LS, Bassani VL, et al. Incorporation of Achyrocline satureioides (Lam.) DC extracts into topical nanoemulsions obtained by means of spontaneous emulsification procedure. Ind Crop Prod. 2014;62:421–9. doi:10.1016/j.indcrop.2014.08.042.
Carvalho ELS, Poser GLV, Zorzi GK, Teixeira HF, Moreira JCF, Bassani VL. Nanoestrutura compreendendo extratos vegetais, processo de produção de nanoestrutura compreendendo extratos vegetais e composições compreendendo as mesmas. Brazil: Universidade Federal do Rio Grande do Sul; 2008.
Zorzi GK, Caregnato F, Moreira JCF, Teixeira H, Carvalho ELS. Antioxidant effect of nanoemulsions containing extract of Achyrocline satureioides (Lam) D.C.—Asteraceae. AAPS PharmSciTech. 2015.
Iversen T-G, Skotland T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today. 2011;6(2):176–85. doi:10.1016/j.nantod.2011.02.003.
Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78(1):857–902. doi:10.1146/annurev.biochem.78.081307.110540.
Sarpietro MG, Giuffrida MC, Ottimo S, Micieli D, Castelli F. Evaluation of the interaction of coumarins with biomembrane models studied by differential scanning calorimetry and Langmuir–Blodgett techniques. J Nat Prod. 2011;74(4):790–5. doi:10.1021/np100850u.
Hunter RJ. Foundations of colloid science. 2nd ed. Oxford: Oxford University Press; 2001.
Hunter RJ. Zeta potential in colloid science: principles and applications. London: Academic; 1989.
Peeters L, Sanders NN, Braeckmans K, Boussery K, de Voorde JV, De Smedt SC, et al. Vitreous: a barrier to nonviral ocular gene therapy. Invest Ophthalmol Vis Sci. 2005;46(10):3553–61.
Rabinovich-Guilatt L, Couvreur P, Lambert G, Dubernet C. Cationic vectors in ocular drug delivery. J Drug Target. 2004;12(9–10):623–33.
Sahoo SK, Dilnawaz F, Krishnakumar K. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13(3/4):144–51.
Amelinckx S, van Dyck D, van Landuyt J, van Tendeloo G. Electron microscopy. Principles and fundamentals. Darmstadt: Wiley-VCH; 2008.
Berne BJ, Pecora R. Dynamic light scattering: with applications to chemistry, biology, and physics. Mineola: Dover; 2003.
Pradines B, Bories C, Vauthier C, Ponchel G, Loiseau P, Bouchemal K. Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against Trichomonas vaginalis and non-toxic towards pig vaginal mucosa. Pharm Res. 2014:1–8. doi: 10.1007/s11095-014-1528-7.
Ezz Eldin H, Sarhan R. Cytotoxic effect of organic solvents and surfactant agents on Acanthamoeba castellanii cysts. Parasitol Res. 2014;113(5):1949–53. doi:10.1007/s00436-014-3845-5.
Acknowledgments
The authors want to thank the Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES) and National Council for Scientific and Technological Development (CNPq) for the financial support. L.P. wishes to thank CAPES for her Graduate fellowship. G.Z. wishes to thank the CNPq (Programa Jovens Talentos—grant number 028/2012) for his postdoctoral grant.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Panatieri, L.F., Brazil, N.T., Faber, K. et al. Nanoemulsions Containing a Coumarin-Rich Extract from Pterocaulon balansae (Asteraceae) for the Treatment of Ocular Acanthamoeba Keratitis. AAPS PharmSciTech 18, 721–728 (2017). https://doi.org/10.1208/s12249-016-0550-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-016-0550-y